MAVIRET® receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus

AbbVie (NYSE: ABBV) announced today that Health Canada has approved MAVIRET (glecaprevir/pibrentasvir tablets) for the treatment of acute and chronic hepatitis C virus (HCV) infection in adults and ...
clinicaladvisor.com

Managing Hepatitis C in Treatment-Naïve Patients With HIV Coinfection

Hepatitis C infection. Computer illustration showing liver and close-up view of hepatitis C viruses. Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection ...
Medscape

Integrating Telemedicine for HCV With Opioid Use Disorder Treatment Works

People with opioid use disorder (OUD) who have hepatitis C virus (HCV) were twice as likely to be treated and cured of HCV if they received facilitated telemedicine treatment within their opioid ...
Medscape

In HCV, Starting Treatment Trumps Staging for Liver Fibrosis

When managing patients with hepatitis C virus (HCV), initiating treatment of the infection promptly is more important than determining the severity of their liver disease with the customary staging ...
Healio

To initiate same-day hepatitis C testing and treatment, hepatitis B status must be known

Please provide your email address to receive an email when new articles are posted on . The FDA’s recent authorization of a rapid, point-of-care test to diagnose current hepatitis C virus infection is ...
clinicaladvisor.com

Peer TeleHCV Model Increases Treatment Initiation, Viral Clearance

Compared with enhanced usual care, peer-assisted telemedicine hepatitis C virus (HCV) treatment significantly increased HCV treatment initiation and viral clearance. Hepatitis C virus (HCV) treatment ...
Medicine Buffalo

Telemedicine treatment for HCV more than twice as successful as off-site referral in those with opioid use disorder

People with opioid use disorder who have hepatitis C virus (HCV) were twice as likely to be successfully treated and cured from HCV if they received facilitated telemedicine treatment at their opioid ...
Nasdaq

Atea Pharmaceuticals Launches Phase 3 C-FORWARD Trial for HCV Treatment Regimen Combining Bemnifosbuvir and Ruzasvir

Atea Pharmaceuticals has announced the initiation of the Phase 3 C-FORWARD trial, which evaluates the combination regimen of bemnifosbuvir and ruzasvir for treating hepatitis C virus (HCV). This trial ...
Healio

HCV elimination represents ‘win-win-win’ for patients, public health, cost savings

Please provide your email address to receive an email when new articles are posted on . Every year nearly 3 million patients are diagnosed with hepatitis B and C infections, ultimately leading to 1.1 ...
Health Affairs

To Eliminate HCV Among Persons Who Use Drugs: Embrace The Complexity

As described in a recent JAMA Viewpoint, the proposed national HCV elimination program intends to engage underserved populations in need of HCV treatment by working closely with grassroots ...
MedPage Today

Hepatitis C Vaccine Is Essential for Expediting Elimination

Pelosi is a scientific manager and researcher. Perkins is a senior advisor in governance. Remak is a patient advocate. Seid is a vaccine program lead. Romanowska is a fact-checking expert addressing ...